CDK9 Antikörper (N-Term)
Kurzübersicht für CDK9 Antikörper (N-Term) (ABIN925994)
Target
Alle CDK9 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- N-Term
-
Kreuzreaktivität
- Hund, Maus, Ratte (Rattus), Huhn, Zebrafisch (Brachydanio rerio), Rind (Kuh), Schwein, Frosch
-
Immunogen
- CDK9 antibody was raised in rabbit using the N terminal of CDK9 as the immunogen
-
-
-
-
Applikationshinweise
- Optimal conditions should be determined by the investigator.
-
Kommentare
-
CDK9 Blocking Peptide, catalog no. 33R-7070, is also available for use as a blocking control in assays to test for specificity of this CDK9 antibody
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Konzentration
- Lot specific
-
Buffer
- Lyophilized powder. Add 100 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
-
Handhabung
- Avoid repeated freeze/thaw cycles.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
-
-
- CDK9 (Cyclin-Dependent Kinase 9 (CDK9))
-
Andere Bezeichnung
- CDK9
-
Hintergrund
- CDK9 is the member of the cyclin-dependent kinase pair (CDK9/cyclin-T) complex, also called positive transcription elongation factor b (P-TEFb), which facilitates the transition from abortive to production elongation by phosphorylating the CTD of the large subunit of RNA polymerase II (RNAP II), SUPT5H and RDBP. The CDK9/cyclin-K complex has also a kinase activity toward CTD of RNAP II and can substitute for P-TEFb in vitro. Synonyms: Polyclonal CDK9 antibody, Anti-CDK9 antibody, cyclin-dependent kinase 9, CDC2-related kinase antibody, RP11-228B15.5 antibody, C-2k antibody, CDC2L4 antibody, PITALRE antibody, TAK antibody.
-
Pathways
- Zellzyklus
Target
-